
Genesco (GCO) is expected to report a year-over-year earnings decline despite a projected 1.4% increase in revenue to $463.91 million for the quarter ending April 2025; the consensus EPS estimate has been revised down 7.74% over the last 30 days to a loss of $2.14 per share. With a negative Earnings ESP of -2.80% and a Zacks Rank of #2, the likelihood of Genesco beating EPS estimates is uncertain, suggesting investors should consider other factors beyond the earnings release on June 4.
Genesco (GCO) faces a challenging outlook for its upcoming Q1 2025 earnings report, with consensus estimates pointing to a year-over-year decline in earnings despite an anticipated 1.4% increase in revenues to $463.91 million. The market expects a quarterly loss of $2.14 per share, representing a 1.9% negative change from the prior year. Notably, the consensus EPS estimate has been revised downwards by 7.74% over the last 30 days, indicating a growing bearish sentiment among analysts regarding the company's near-term profitability. Genesco's Zacks Earnings ESP (Expected Surprise Prediction) is -2.80%, as the Most Accurate Estimate is lower than the Zacks Consensus Estimate; this negative ESP, according to Zacks methodology, makes it difficult to conclusively predict an earnings beat, despite the stock currently holding a Zacks Rank of #2 (Buy). While the company has beaten consensus EPS estimates three times in the last four quarters, it reported a -1.51% earnings surprise miss in the most recent quarter. The combination of these factors suggests Genesco is not a compelling candidate for an earnings beat in its report expected on June 4, and management's discussion on business conditions will be pivotal for future expectations.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately negative
Sentiment Score
-0.45
Ticker Sentiment